Annual SG&A
$50.91 M
-$20.64 M-28.85%
31 December 2023
Summary:
Atara Biotherapeutics annual selling, general & administrative expenses is currently $50.91 million, with the most recent change of -$20.64 million (-28.85%) on 31 December 2023. During the last 3 years, it has fallen by -$13.49 million (-20.95%). ATRA annual SG&A is now -36.03% below its all-time high of $79.58 million, reached on 31 December 2019.ATRA Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$10.42 M
+$1.51 M+16.93%
30 September 2024
Summary:
Atara Biotherapeutics quarterly selling, general & administrative expenses is currently $10.42 million, with the most recent change of +$1.51 million (+16.93%) on 30 September 2024. Over the past year, it has dropped by -$1.83 million (-14.91%). ATRA quarterly SG&A is now -55.24% below its all-time high of $23.28 million, reached on 30 June 2019.ATRA Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$8.03 B
-$133.16 M-1.69%
30 September 2024
Summary:
Atara Biotherapeutics TTM selling, general & administrative expenses is currently -$8.03 billion, with the most recent change of -$133.16 million (-1.69%) on 30 September 2024. Over the past year, it has dropped by -$8.08 billion (-15341.02%). ATRA TTM SG&A is now -62244.66% below its all-time high of $81.63 million, reached on 31 March 2022.ATRA TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATRA Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.9% | -14.9% | -10000.0% |
| 3 y3 years | -20.9% | -47.5% | -10000.0% |
| 5 y5 years | -26.9% | -45.2% | -10000.0% |
ATRA Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -35.4% | at low | -52.2% | +16.9% | -61.1% | at low |
| 5 y | 5 years | -36.0% | at low | -52.2% | +16.9% | -217.8% | at low |
| alltime | all time | -36.0% | +1255.4% | -55.2% | +1215.8% | <-9999.0% | at low |
Atara Biotherapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $10.42 M(+16.9%) | $41.90 M(-4.2%) |
| June 2024 | - | $8.91 M(-19.8%) | $43.73 M(-9.2%) |
| Mar 2024 | - | $11.11 M(-3.0%) | $48.15 M(-5.4%) |
| Dec 2023 | $50.91 M(-28.9%) | $11.45 M(-6.5%) | $50.91 M(-3.4%) |
| Sept 2023 | - | $12.25 M(-8.2%) | $52.70 M(-11.2%) |
| June 2023 | - | $13.34 M(-3.9%) | $59.38 M(-8.4%) |
| Mar 2023 | - | $13.87 M(+4.7%) | $64.85 M(-9.4%) |
| Dec 2022 | $71.55 M(-9.2%) | $13.24 M(-30.0%) | $71.55 M(-10.7%) |
| Sept 2022 | - | $18.92 M(+0.6%) | $80.13 M(-1.1%) |
| June 2022 | - | $18.81 M(-8.5%) | $81.05 M(-0.7%) |
| Mar 2022 | - | $20.57 M(-5.7%) | $81.63 M(+3.6%) |
| Dec 2021 | $78.80 M(+22.4%) | $21.82 M(+9.9%) | $78.80 M(+7.8%) |
| Sept 2021 | - | $19.85 M(+2.3%) | $73.13 M(+7.4%) |
| June 2021 | - | $19.40 M(+9.4%) | $68.11 M(+4.6%) |
| Mar 2021 | - | $17.74 M(+9.9%) | $65.10 M(+1.1%) |
| Dec 2020 | $64.40 M(-19.1%) | $16.14 M(+8.9%) | $64.40 M(-2.9%) |
| Sept 2020 | - | $14.83 M(-9.5%) | $66.32 M(-5.9%) |
| June 2020 | - | $16.39 M(-3.8%) | $70.51 M(-8.9%) |
| Mar 2020 | - | $17.04 M(-5.7%) | $77.40 M(-2.7%) |
| Dec 2019 | $79.58 M(+14.3%) | $18.06 M(-5.0%) | $79.58 M(-1.9%) |
| Sept 2019 | - | $19.02 M(-18.3%) | $81.09 M(+2.7%) |
| June 2019 | - | $23.28 M(+21.1%) | $78.93 M(+5.4%) |
| Mar 2019 | - | $19.22 M(-1.7%) | $74.89 M(+7.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $69.65 M(+72.7%) | $19.56 M(+16.0%) | $69.65 M(+14.0%) |
| Sept 2018 | - | $16.86 M(-12.3%) | $61.12 M(+10.5%) |
| June 2018 | - | $19.24 M(+37.5%) | $55.32 M(+21.1%) |
| Mar 2018 | - | $13.99 M(+26.8%) | $45.70 M(+13.3%) |
| Dec 2017 | $40.33 M(+63.1%) | $11.03 M(-0.3%) | $40.33 M(+16.6%) |
| Sept 2017 | - | $11.06 M(+15.1%) | $34.58 M(+12.8%) |
| June 2017 | - | $9.61 M(+11.5%) | $30.65 M(+11.3%) |
| Mar 2017 | - | $8.62 M(+63.3%) | $27.53 M(+11.3%) |
| Dec 2016 | $24.73 M(+46.9%) | $5.28 M(-26.1%) | $24.73 M(-1.0%) |
| Sept 2016 | - | $7.14 M(+9.9%) | $24.99 M(+13.6%) |
| June 2016 | - | $6.49 M(+11.7%) | $21.99 M(+15.1%) |
| Mar 2016 | - | $5.81 M(+5.0%) | $19.10 M(+13.5%) |
| Dec 2015 | $16.83 M(+32.4%) | $5.54 M(+33.6%) | $16.83 M(-0.1%) |
| Sept 2015 | - | $4.15 M(+15.1%) | $16.84 M(+16.9%) |
| June 2015 | - | $3.60 M(+1.6%) | $14.40 M(+18.4%) |
| Mar 2015 | - | $3.54 M(-36.1%) | $12.16 M(-4.3%) |
| Dec 2014 | $12.71 M(+238.4%) | $5.55 M(+224.8%) | $12.71 M(+52.6%) |
| Sept 2014 | - | $1.71 M(+25.8%) | $8.33 M(+11.2%) |
| June 2014 | - | $1.36 M(-66.8%) | $7.49 M(+8.2%) |
| Mar 2014 | - | $4.10 M(+251.6%) | $6.92 M(+84.2%) |
| Dec 2013 | $3.76 M | $1.17 M(+34.2%) | $3.76 M(+44.9%) |
| Sept 2013 | - | $868.00 K(+9.6%) | $2.59 M(+50.3%) |
| June 2013 | - | $792.00 K(-15.0%) | $1.72 M(+85.0%) |
| Mar 2013 | - | $932.00 K | $932.00 K |
FAQ
- What is Atara Biotherapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Atara Biotherapeutics?
- What is Atara Biotherapeutics annual SG&A year-on-year change?
- What is Atara Biotherapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Atara Biotherapeutics?
- What is Atara Biotherapeutics quarterly SG&A year-on-year change?
- What is Atara Biotherapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Atara Biotherapeutics?
- What is Atara Biotherapeutics TTM SG&A year-on-year change?
What is Atara Biotherapeutics annual selling, general & administrative expenses?
The current annual SG&A of ATRA is $50.91 M
What is the all time high annual SG&A for Atara Biotherapeutics?
Atara Biotherapeutics all-time high annual selling, general & administrative expenses is $79.58 M
What is Atara Biotherapeutics annual SG&A year-on-year change?
Over the past year, ATRA annual selling, general & administrative expenses has changed by -$20.64 M (-28.85%)
What is Atara Biotherapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of ATRA is $10.42 M
What is the all time high quarterly SG&A for Atara Biotherapeutics?
Atara Biotherapeutics all-time high quarterly selling, general & administrative expenses is $23.28 M
What is Atara Biotherapeutics quarterly SG&A year-on-year change?
Over the past year, ATRA quarterly selling, general & administrative expenses has changed by -$1.83 M (-14.91%)
What is Atara Biotherapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of ATRA is -$8.03 B
What is the all time high TTM SG&A for Atara Biotherapeutics?
Atara Biotherapeutics all-time high TTM selling, general & administrative expenses is $81.63 M
What is Atara Biotherapeutics TTM SG&A year-on-year change?
Over the past year, ATRA TTM selling, general & administrative expenses has changed by -$8.08 B (-15341.02%)